Search
Search Funnelback University
- Refined by:
- Date: Past month
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk. Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
1 -
10 of
16
search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk
where 0
match all words and 16
match some words.
Results that match 1 of 2 words
-
Latest news, case studies and blogs – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/latest-news/
11 Apr 2024:
Catch up on our latest developments to see how we're creating impact for the benefit of society, the economy and the University.
-
Dr Christine Martin - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/team/dr-christine-martin/
20 Mar 2024:
She is the author of over 20 peer reviewed journal articles and over 20 patents.
-
Start a company or social venture – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/start-a-company-or-social-enterprise/25 Mar 2024: Why start a company or social enterprise with us? Over 20 years' experience. ... Over 20 years of seed investing at the University of Cambridge has seen a host of successes including XO1, BlueGnome, Cambridge CMOS Sensors, Lumora, Quethera and VocalIQ. -
Ventures – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-team/ventures/20 Mar 2024: She is the author of over 20 peer reviewed journal articles and over 20 patents. ... She has more than 20 years experience advising on corporate legal matters especially for investments into spin outs of the University in the technology and life sciences -
Opportunities to invest in early stage companies – Cambridge…
https://www.enterprise.cam.ac.uk/for-external-organisations/opportunities-to-invest/28 Mar 2024: Over 20 years of seed investing at the University of Cambridge has seen a host of successes including XO1, BlueGnome, Cambridge CMOS Sensors, Lumora, Quethera and VocalIQ. -
MAT2A inhibitors to treat BK polyomavirus disease – Cambridge…
https://www.enterprise.cam.ac.uk/opportunities/mat2a-inhibitors-to-treat-bk-polyomavirus-disease/
19 Apr 2024:
Technology is the first specific treatment for BKPyV-associated diseases (e.g. PVAN and HC) in immunosuppressed patients, holding the potential to benefit around 20,000 affected transplant recipients annually.
-
Frequently Asked Questions (FAQs) - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/contact/faqs/26 Mar 2024: Once granted, the term of a patent, or the time it is enforceable, is of 20 years from the initial filing. -
Innovation.Partnership.Impact. ANNUAL REVIEW 2023 The University of…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/CE_Annual_Report23_WEB.pdf26 Mar 2024: 18 NuQuantum: pioneering Quantum Networking for transformative computing. 20 Establishing a home-grown, inclusive innovation roadmap to prosperity for Greater Cambridge. ... 06 OCTOBER. 20 MARCH. £29.8bn economic impact of the University of Cambridge -
Revenue sharing – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/revenue-sharing/17 Apr 2024: 5%. 5%. Next £100,000 (£197,649 RPI). 60%. 20%. 20%. Above £200,000 (£395,298 RPI). -
Meet our Senior Leadership – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-team/senior-leadership/20 Mar 2024: Caroline has spent over 20 years working with entrepreneurship and innovation in and around Cambridge and is well networked in the Cambridge ecosystem. ... She is the author of over 20 peer reviewed journal articles and over 20 patents.
11 Apr 2024:
Catch up on our latest developments to see how we're creating impact for the benefit of society, the economy and the University.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.